BARCLAYS PLC - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 138 filers reported holding TREACE MED CONCEPTS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$199
-58.1%
16,340
-15.2%
0.00%
Q2 2023$475
-0.8%
19,274
+3.5%
0.00%
Q1 2023$479
+128.1%
18,621
+107.9%
0.00%
Q4 2022$210
-99.3%
8,955
+533.3%
0.00%
Q3 2022$32,000
-56.2%
1,414
-72.1%
0.00%
Q2 2022$73,000
-53.5%
5,068
-39.3%
0.00%
Q1 2022$157,0008,3500.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q2 2023
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,595,387$36,677,9474.40%
EMERALD MUTUAL FUND ADVISERS TRUST 945,973$21,747,9191.35%
EMERALD ADVISERS, LLC 1,188,246$27,317,7761.32%
Perceptive Advisors 1,946,403$44,747,8051.26%
Novo Holdings A/S 637,317$14,651,9180.92%
SECTORAL ASSET MANAGEMENT INC 179,924$4,136,4530.80%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 493,213$11,338,9670.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 139,960$3,2180.50%
TimesSquare Capital Management, LLC 976,000$22,4380.32%
DRIEHAUS CAPITAL MANAGEMENT LLC 770,817$17,721,0830.26%
View complete list of TREACE MED CONCEPTS INC shareholders